Summary of Professor Xiong Shaoquan’s experience in the treatment of refractory chemo-therapy-induced thrombocytopenia in patients with malignant tumors with “Sanwei Shenghuo Dan”
LUO Yingzhe LI Ru XIONG Shaoquan HE Lifang HUANG Xingmei WU Guoyu
The First Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 610072, China
Abstract:Due to repeated chemotherapy in patients, refractory chemo-therapy-induced thrombocytopenia is a side effect of chemotherapy, which manifests as irreversible bone marrow hematopoietic dysfunction. Routine use of platelet-promoting factors such as recombinant human thrombopoietin, interleukin-11 and etc. has been difficult to achieve ideal clinical efficacy. Professor Xiong Shaoquan believes that the internal binding of static blood and poison caused the deficiency of the spleen kidney, and other viscera. Repeated chemotherapy leads to damaging the kidney yin and yin deficiency involving yang which results to the decline of vital gate fire. Therefore, Professor Xiong Shaoquan proposes that the main pathogenesis of this disease is “decline of vital gate fire and the deficiency of both kidney yin and yang” and created the “Sanwei Shenghuo Dan” to treat the disease. “Sanwei Shenghuo Dan” is composed of Aconiti Lateralis Radix Praeparata, Polygonati Rhizoma, Jujubae Fructus. The three herbs are prepared in a ratio of 1∶1∶1. According to the specific situation, “Sanwei Shenghuo Dan” need to be used in addition or subtraction others herbs on the basis of this prescription. On the one hand, replenishing the vital gate fire to strengthen the kidney yang; on the other hand, strengthening zhongzhou to produce the middle qi. When the kidney fire is strong, qi and blood grow, and when the middle qi is sufficient, the qi and blood biochemistry are active and the platelets can be restored to normal. A case study is attached in order to provide new ideas and methods for the clinical prevention and treatment of refractory chemo-therapy-induced thrombocytopenia.
骆颖哲 李茹 熊绍权 何粒芳 黄兴梅 吴国玉. 熊绍权教授运用“三味生火丹”治疗恶性肿瘤患者化疗相关难治性血小板减少症的经验总结[J]. 中国医药导报, 2022, 19(31): 122-125.
LUO Yingzhe LI Ru XIONG Shaoquan HE Lifang HUANG Xingmei WU Guoyu. Summary of Professor Xiong Shaoquan’s experience in the treatment of refractory chemo-therapy-induced thrombocytopenia in patients with malignant tumors with “Sanwei Shenghuo Dan”. 中国医药导报, 2022, 19(31): 122-125.